$204.10 2.4%
PODD Stock Price vs. AI Score (Last 150 days)
Data gathered: June 22

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.

Price $204.10
Target Price Sign up
Volume 1,030,000
Market Cap $14B
Year Range $130.76 - $221.42
Dividend Yield 0%
PE Ratio 59.85
Revenue per Employee $684,885
Industry Medical Devices

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24442M135M307M52M68M0.730
Q4 '23510M149M361M103M117M1.400
Q3 '23433M139M293M52M67M0.710
Q2 '23397M132M265M27M41M0.380
Q1 '23358M118M241M24M36M0.230

Insider Transactions View All

Field Mark N filed to sell 12,875 shares at $200.
June 17 '24
Field Mark N filed to sell 14,375 shares at $190.4.
June 11 '24
Scannell Timothy J filed to sell 35,586 shares at $190.5.
June 11 '24
BORIO LUCIANA filed to sell 3,298 shares at $182.6.
June 5 '24
Scannell Timothy J filed to sell 42,586 shares at $180.9.
May 29 '24

Congress Trading View All

Politician Filing Date Type Size
Christine Smith
Apr 19, 24 Sell $50K - $100K
Markwayne Mullin
Jan 26, 24 Sell $1K - $15K
Rohit Khanna
Nov 8, 23 Sell $1K - $15K

What is the Market Cap of Insulet?

The Market Cap of Insulet is $14B.

What is Insulet's PE Ratio?

As of today, Insulet's PE (Price to Earnings) ratio is 59.85.

How Many People Work at Insulet?

As of our latest update, Insulet employed approximately 2,600 people worldwide. However, it's important to note that Insulet's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Insulet's revenue per employee?

$684,885. To calculate Insulet's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Insulet?

Currently, the price of one share of Insulet stock is $204.10.

How can I analyze the PODD stock price chart for investment decisions?

The PODD stock price chart above provides a comprehensive visual representation of Insulet's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Insulet shares. Our platform offers an up-to-date PODD stock price chart, along with technical data analysis and alternative data insights.

Does PODD offer dividends to its shareholders?

As of our latest update, Insulet (PODD) does not offer dividends to its shareholders. Investors interested in Insulet should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Insulet?

Some of the similar stocks of Insulet are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.